These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1773549)

  • 1. Pharmacokinetic interactions with calcium channel antagonists (Part I).
    Schlanz KD; Myre SA; Bottorff MB
    Clin Pharmacokinet; 1991 Nov; 21(5):344-56. PubMed ID: 1773549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic interactions with calcium channel antagonists (Part II).
    Schlanz KD; Myre SA; Bottorff MB
    Clin Pharmacokinet; 1991 Dec; 21(6):448-60. PubMed ID: 1782739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug interactions].
    D'arcy PF
    J Pharm Belg; 1984; 39(1):53-62. PubMed ID: 6144745
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug interactions in the treatment of arterial hypertension: an emerging problem].
    Casiglia E; Gava R; Giacomello M; Cima L; Giusti P; Pessina AC
    Clin Ter; 1987 Nov; 123(3):177-83. PubMed ID: 2902951
    [No Abstract]   [Full Text] [Related]  

  • 5. Lercanidipine: short plasma half-life, long duration of action and high cholesterol tolerance. Updated molecular model to rationalize its pharmacokinetic properties.
    Herbette LG; Vecchiarelli M; Sartani A; Leonardi A
    Blood Press Suppl; 1998; 2():10-7. PubMed ID: 9850437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Principles of the pharmacokinetics and pharmacodynamics of calcium antagonists].
    Rameis H
    Wien Med Wochenschr; 1993; 143(19-20):490-500. PubMed ID: 8135031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro.
    Vilpo J; Koski T; Vilpo L
    Haematologica; 2000 Aug; 85(8):806-13. PubMed ID: 10942926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of some drugs on the pharmacokinetics or pharmacodynamics of MPC-1304, a dihydropyridine Ca2+ antagonist.
    Nakano M; Miyoshi K; Umeno Y; Yoshida K; Nishizaki J; Miyake H
    Arch Int Pharmacodyn Ther; 1996; 331(2):109-23. PubMed ID: 8937623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Issues in drug metabolism of major antihypertensive drugs: beta-blockers, calcium channel antagonists and angiotensin receptor blockers.
    Höcht C; Bertera FM; Mayer MA; Taira CA
    Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):199-211. PubMed ID: 20095790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetic interaction of drugs with cardiac glycosides; which are clinically important?].
    Hooymans PM; Merkus FW
    Ned Tijdschr Geneeskd; 1986 Mar; 130(9):395-9. PubMed ID: 2870436
    [No Abstract]   [Full Text] [Related]  

  • 11. [Interactions between anti-hypertensive and non-antihypertensive drugs].
    Sugimoto T; Matsuoka H
    Nihon Rinsho; 1992 May; 50 Suppl():28-33. PubMed ID: 1355128
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta blockers 1984. Part 2.
    Wing LM
    Aust Fam Physician; 1984 Aug; 13(8):604, 606, 608. PubMed ID: 6149740
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of the T-type Ca(2+) channel blocker mibefradil on repolarization of guinea pig, rabbit, dog, monkey, and human cardiac tissue.
    Bénardeau A; Weissenburger J; Hondeghem L; Ertel EA
    J Pharmacol Exp Ther; 2000 Feb; 292(2):561-75. PubMed ID: 10640293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium antagonists--adverse drug interactions.
    Reicher-Reiss H; Neufeld HN; Ebner FX
    Cardiovasc Drugs Ther; 1987 Dec; 1(4):403-9. PubMed ID: 2908714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug interactions with the calcium-entry blockers.
    Piepho RW; Culbertson VL; Rhodes RS
    Circulation; 1987 Jun; 75(6 Pt 2):V181-94. PubMed ID: 2882874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amlodipine: pharmacokinetic profile of a low-clearance calcium antagonist.
    Abernethy DR
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S4-7. PubMed ID: 16296697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of cardiac glycoside drug interactions.
    Hooymans PM; Merkus FW
    Clin Pharm; 1985; 4(4):404-13. PubMed ID: 2412751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic and anti-ischemic properties of calcium-channel antagonists.
    Apostolakos MJ; Varon ME
    New Horiz; 1996 Feb; 4(1):45-57. PubMed ID: 8689275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical pharmacology of calcium antagonists].
    Lauterburg BH
    Schweiz Med Wochenschr; 1987 Mar; 117(13):496-501. PubMed ID: 3576161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug interactions in anesthesiology and resuscitation: neuromuscular blockers, benzodiazepines and calcium antagonists].
    Carlos García R
    Rev Esp Anestesiol Reanim; 1991; 38(5):291-2. PubMed ID: 1665241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.